Xiaobing Zhang

Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis

Zhou-Ji Zhang, Zhi-gang He, Zhenshun Song, 2017, Cancer biology & therapy.

Proteomics‐based identification of the role of osteosarcoma amplified‐9 in hepatocellular carcinoma recurrence

Xu‐yong Wei, Beini Cen, Kun Wang, 2022, Hepatology communications.

Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study

Yu-Ting Wu, Lixin Wei, Jin Zhang, 2022, Frontiers in Oncology.

miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance

Yue Wu, Dong-hao Wu, Hengyu Li, 2020, Journal of Cancer.

Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis

Sylvia E. Le Dévédec, J. Martens, H. Ovaa, 2019, Clinical Cancer Research.

Antioxidant and C5a-blocking strategy for hepatic ischemia–reperfusion injury repair

W. Cai, J. Engle, Dalong Ni, 2021, Journal of Nanobiotechnology.

A Pretreatment CT Model Predicts Survival Following Chemolipiodolization in Patients With Hepatocellular Carcinoma

W. Lau, Lixin Wei, Dong-hao Wu, 2019, Technology in cancer research & treatment.

Immunosuppressive CD10+ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC ​by mediating irreversible exhaustion of T cells.

Wenjia Wang, Yan Meng, Fei Ye, 2023, Journal of hepatology.